RECRUITING

Mg OSTEOCRETE Post-Treatment Outcomes

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Mg OSTEOCRETE is a bone substitute used to fill a defect in bone caused by excision of a tumor, orthopaedic hardware that has become loosened, or a trauma-related condition. The aim of this study is to determine the amount of time it takes for bone to heal after treatment with Mg OSTEOCRETE, and to better understand the efficacy of this treatment through clinical and patient-reported outcomes.

Official Title

Clinical and Radiographic Outcomes of Patients Treated With Mg OSTEOCRETE

Quick Facts

Study Start:2025-03-17
Study Completion:2026-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06720142

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18 years of age and older on the day of surgery
  2. * has received or will receive Mg OSTEOCRETE as a component of their treatment at this institution in accordance with Instructions for Use for the implanted product
  3. * Mg OSTEOCRETE is indicated for one of the following reasons:
  4. 1. as a bone void filler following bone tumor resection, or;
  5. 2. as an augment for defects causing aseptic loosening of orthopaedic implants, or;
  6. 3. to help substitute bone for trauma-related conditions
  1. * any contraindication as per Instructions for Use for Mg OSTEOCRETE

Contacts and Locations

Study Contact

Lucy L Hederick, BA
CONTACT
617-726-4932
lhederick@mgh.harvard.edu
Santiago A Lozano-Calderon, MD, PhD
CONTACT
617-643-4947

Principal Investigator

Santiago A Lozano-Calderon, MD, PhD
PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital

Study Locations (Sites)

Massachusetts General Hospital
Boston, Massachusetts, 02114
United States

Collaborators and Investigators

Sponsor: Santiago Lozano-Calderon

  • Santiago A Lozano-Calderon, MD, PhD, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03-17
Study Completion Date2026-06

Study Record Updates

Study Start Date2025-03-17
Study Completion Date2026-06

Terms related to this study

Keywords Provided by Researchers

  • bone defect
  • bone substitute
  • osteocrete

Additional Relevant MeSH Terms

  • Cancer of Bone
  • Trauma
  • Aseptic Loosening of Orthopaedic Hardware